Azenta Inc (AZTA)
49.38
+0.20
(+0.41%)
USD |
NASDAQ |
Sep 27, 16:00
49.37
-0.01
(-0.02%)
After-Hours: 20:00
Azenta SG&A Expense (Annual): 316.28M for Sept. 30, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
September 30, 2023 | 316.28M |
September 30, 2022 | 251.46M |
September 30, 2021 | 252.10M |
September 30, 2020 | 190.26M |
September 30, 2019 | 163.33M |
September 30, 2018 | 167.02M |
September 30, 2017 | 141.55M |
September 30, 2016 | 119.29M |
September 30, 2015 | 115.27M |
September 30, 2014 | 111.10M |
September 30, 2013 | 96.52M |
September 30, 2012 | 97.98M |
September 30, 2011 | 102.54M |
September 30, 2010 | 85.60M |
September 30, 2009 | 91.23M |
Date | Value |
---|---|
September 30, 2008 | 110.52M |
September 30, 2007 | 120.42M |
September 30, 2006 | 117.22M |
September 30, 2005 | 84.80M |
September 30, 2004 | 87.07M |
September 30, 2003 | 95.60M |
September 30, 2002 | 101.20M |
September 30, 2001 | 95.92M |
September 30, 2000 | 77.41M |
September 30, 1999 | 34.40M |
September 30, 1998 | 31.60M |
September 30, 1997 | 24.90M |
September 30, 1996 | 22.90M |
September 30, 1995 | 11.80M |
September 30, 1994 | 6.50M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
163.33M
Minimum
2019
316.28M
Maximum
2023
234.69M
Average
251.46M
Median
2022
SG&A Expense (Annual) Benchmarks
Bruker Corp | 730.10M |
Harvard Bioscience Inc | 46.89M |
Bionano Genomics Inc | 93.50M |
Akoya Biosciences Inc | 82.38M |
Singular Genomics Systems Inc | 54.48M |